Case number 3:24-cv-08167
ASTRAZENECA PHARMACEUTICALS LP et al v. CIPLA LIMITED et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 21, 2024 | 16 | ANSWER to Counterclaim by ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH.(CHEVALIER, CHARLES) (Entered: 10/21/2024) (9) |
| Oct 7, 2024 | 14 | ANSWER to Complaint , COUNTERCLAIM against ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH by CIPLA LIMITED, CIPLA USA, INC..(TOR, LOLY) (Entered: 10/07/2024) (30) |
| Oct 7, 2024 | 15 | Corporate Disclosure Statement by CIPLA LIMITED, CIPLA USA, INC. identifying InvaGen Pharmaceuticals, Inc. as Corporate Parent.. (TOR, LOLY) (Entered: 10/07/2024) (2) |
| Aug 12, 2024 | 12 | PRETRIAL CONSOLIDATION ORDER Directing that all papers be filed and maintained in Civil Action No. 23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/12/2024. (amv) (Entered: 08/13/2024) (7) |
| Aug 12, 2024 | 13 | STIPULATION AND CONSOLIDATED AMENDED PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/12/2024. (amv) (Entered: 08/13/2024) (8) |
| Aug 9, 2024 | 11 | Letter from Charles H. Chevalier, Esq. to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: # 1 [Proposed] Amended Scheduling Order, # 2 [Proposed] Consolidation Order, # 3 [Proposed] Second Supplemental Stipulated Discovery Confidentiality Order)(CHEVALIER, CHARLES) (Entered: 08/09/2024) (0) |
| Aug 6, 2024 | 9 | WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. CIPLA LIMITED waiver sent on 8/6/2024, answer due 10/7/2024. (CHEVALIER, CHARLES) (Entered: 08/06/2024) (1) |
| Aug 6, 2024 | 10 | WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. CIPLA USA, INC. waiver sent on 8/6/2024, answer due 10/7/2024. (CHEVALIER, CHARLES) (Entered: 08/06/2024) (1) |
| Jul 31, 2024 | 1 | COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746) , Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024) (0) |
| Jul 31, 2024 | 2 | Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024) (2) |
| Jul 31, 2024 | 3 | Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024) (2) |
| Jul 31, 2024 | 4 | Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024) (2) |
| Jul 31, 2024 | 5 | Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024) (2) |
| Jul 31, 2024 | 6 | Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024) (2) |
| Jul 31, 2024 | N/A | Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (kht) (Entered: 07/31/2024) (0) |
| Jul 31, 2024 | 7 | AO120 Patent/Trademark Form filed. (kht) (Entered: 07/31/2024) (1) |
| Jul 31, 2024 | 8 | SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 07/31/2024) (2) |
